Regulatory
-
R21 Price Cut Unlocks $1 Billion for Malaria Vaccination in Africa
By Zacharia Kafuko (Director of 1Day Africa) and Ollie Sayeed, PhD The international vaccine provider Gavi and the UN children’s...
-
Ripple effects: How U.S. FDA layoffs threaten global health in low- and middle-income countries and weaken US competitiveness
By Philip Kenol & Enlli Lewis The recent staffing cuts at the U.S. Food and Drug Administration (FDA), which affected...
-
Building on the success of Operation Warp Speed
Operation Warp Speed (OWS) was a groundbreaking public-private partnership that accelerated the development of COVID-19 vaccines, setting a model for...
-
Applying Pull Funding & Regulatory Capacity to Advance New Biotechnologies & Prevent Pandemics: Operation Warp Speed 2.0 Conference
Last week, 1Day Sooner convened more than 80 of the nation’s top health, biosecurity, and research leaders for our third...
-
1Day Sooner issues letter to amend CA SB 1308
The California legislature’s proposed SB 1308 aims to reduce ozone and other volatile compounds found in the air. Here at...
-
1Day Sooner’s Comments on SB-1308 and Effects on Germicidal UV Light Technology
By Gavriel Kleinwaks, the lead indoor air quality researcher at 1Day Sooner, a public health nonprofit that pursues campaigns in...
-
1Day Letter: Emerging Pandemic Preparedness Program FY2025 Appropriations
Last year, 1Day Sooner coordinated a letter to the US Secretary of Health and Human Services in support of the...
-
1Day Sooner Letter to OMB on FDA Emerging Pathogens Preparedness Program
On September 26, 2023, 1Day Sooner delivered a letter to Health and Human Services Secretary Xavier Becerra outlining the case...
-
1Day Letter: Establish the FDA Emerging Pathogens Preparedness Program
The Emerging Pathogens Preparedness Program (EPPP) will allow the FDA to better defend against future emerging diseases.
